Green LifeScience Co

Green LifeScience Co FCF/Debt

The Free Cash Flow to Debt Ratio of Green LifeScience Co (114450.KQ) as of Oct 20, 2026 is 1.18 %. In the previous year, Free Cash Flow to Debt Ratio was -2.17 % — a change of -154.16% (higher).

FCF/Debt

1.18 %

YoY

-154.16%

Last updated:

Free Cash Flow to Debt Ratio of Green LifeScience Co is 2024 1.18 % . Free Cash Flow to Debt Ratio of Green LifeScience Co was 2023 -2.17 % . It decreases by -154.16% higher compared to the previous year.

The Green LifeScience Co FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2017
33.10 KRW
Jan 1, 2018
-41.39 KRW
Jan 1, 2019
12.57 KRW
Jan 1, 2020
-12.26 KRW
Jan 1, 2021
-37.81 KRW
Jan 1, 2022
-92.67 KRW
Jan 1, 2023
-2.17 KRW
Jan 1, 2024
1.18 KRW
The Green LifeScience Co FCF/Debt history
YEARFCF/DebtYoY
1.18 %-154.16%
-2.17 %-97.65%
-92.67 %+145.09%
-37.81 %+208.51%
-12.26 %-197.48%
12.57 %-130.38%
-41.39 %-225.06%
33.10 %-52.51%
69.69 %-7.72%
75.53 %+303.86%
18.70 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green LifeScience Co Stock analysis

What does Green LifeScience Co do? Green LifeScience Co Ltd produces and sells pharmaceutical and agricultural raw materials and intermediates, including AMZ for crop protection, TAZD as a herbicide intermediate, D003M and T003M for artificial marble additives, and PM04 as a pharmaceutical intermediate. The company distributes its products domestically and to international markets such as Japan, the United States, and Europe, where customers purchase these materials for agricultural and pharmaceutical applications. The firm also offers antibiotics as part of its product portfolio, targeting both domestic and overseas buyers seeking specialized chemical compounds. Green LifeScience Co Ltd generates revenue through the sale of its chemical products to customers in the agricultural and pharmaceutical sectors, with key markets including Japan, the United States, and European countries. The company’s product line caters to the needs of manufacturers requiring raw materials for crop protection, herbicides, and pharmaceutical production. Its domestic and international distribution channels support consistent sales across these segments, leveraging established relationships with buyers in the chemical supply chain. The company's offerings include specific chemical compounds like AMZ, TAZD, D003M, T003M, and PM04, which are sold to customers who integrate them into larger production processes. These products are used in the creation of crop protection materials, herbicides, artificial marble, and pharmaceuticals, serving both local and global markets. Antibiotics are also part of the sales mix, contributing to the firm’s revenue from chemical intermediates and raw materials. Green LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Green LifeScience Co stock

Free Cash Flow to Debt Ratio of Green LifeScience Co is 1.18 % in 2024.

Free Cash Flow to Debt Ratio of Green LifeScience Co changed from -2.17 % to 1.18 %, representing a -154.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Green LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Green LifeScience Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Green LifeScience Co

All Key Metrics — Green LifeScience Co